Core Viewpoint - The company, Selys Medical Technology Group Co., Ltd., is undergoing changes in its business scope and governance structure, with a focus on expanding into new product categories and preparing for a shareholder meeting to approve these changes [2][4][6]. Group 1: Stock Performance - As of December 26, 2025, Selys Medical's stock closed at 21.48 yuan, down 4.06% from the previous week's 22.39 yuan [1]. - The stock reached a high of 22.5 yuan and a low of 21.16 yuan on December 25, 2025 [1]. - The company's current total market capitalization is 4.515 billion yuan, ranking 24th out of 32 in the pharmaceutical commercial sector and 3628th out of 5178 in the A-share market [1]. Group 2: Corporate Announcements - The fifth board of directors held its 24th meeting on December 22, 2025, where it approved two key resolutions: one to expand the company's business scope and another to convene the first extraordinary general meeting of shareholders in 2026 [2][4]. - The company plans to hold the first extraordinary general meeting of shareholders on January 7, 2026, with both on-site and online voting options available [3][6]. - The proposed expansion of the business scope includes health products, cosmetics, daily chemical products, personal hygiene products, special medical purpose formula foods, pre-packaged foods, health foods, and internet sales [4][6]. Group 3: Corporate Governance - The company's articles of association were revised in December 2025, establishing it as a perpetual joint-stock company with a registered capital of 210,139,246 yuan [5]. - The articles outline shareholder rights and obligations, the powers and rules of the shareholders' meeting, responsibilities of the board of directors and supervisors, and financial accounting policies [5]. - The company aims for a cash dividend priority in profit distribution, with a commitment to distribute no less than 30% of the average distributable profit over the last three years [5].

Core Viewpoint - The stock of Sely Medical has experienced a significant increase of 198.75% this year, but has recently shown a decline in trading performance, with a drop of 3.66% over the last five trading days and 21.39% over the last 60 days [1]. Group 1: Stock Performance - As of December 26, Sely Medical's stock price is 21.57 CNY per share, with a market capitalization of 4.534 billion CNY [1]. - The company has seen a net outflow of 17.64 million CNY in principal funds, with large orders buying 11.94 million CNY and selling 30.74 million CNY [1]. - Sely Medical has appeared on the trading leaderboard 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a year-on-year decrease of 39.64%, and a net profit attributable to shareholders of -87.24 million CNY, down 55.72% year-on-year [2]. - The company has not distributed any dividends in the last three years, with a total payout of 27.07 million CNY since its A-share listing [3]. Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22% from the previous period, with an average of 2,986 circulating shares per person, an increase of 12.64% [2]. - Notable institutional shareholders include Caixin Advantage Industry Rotation Mixed Fund, which increased its holdings by 58.48% to 1.2282 million shares, and new entrants such as GF Healthcare Stock A and others [3].

Core Viewpoint - The stock of Sely Medical has experienced a significant increase of 193.77% this year, but has recently shown a decline in the short term, with a drop of 3.15% over the last five trading days and 23.71% over the last 60 days [1] Group 1: Stock Performance - As of December 25, Sely Medical's stock price is 21.21 CNY per share, with a market capitalization of 4.458 billion CNY [1] - The stock has seen a net outflow of 957,700 CNY in principal funds, with large orders buying 4.3736 million CNY (6.41% of total) and selling 5.3313 million CNY (7.81% of total) [1] - The company has appeared on the "Dragon and Tiger List" 37 times this year, with the most recent appearance on August 26, where it recorded a net purchase of 146 million CNY [1] Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a decrease of 39.64% year-on-year, and a net profit attributable to shareholders of -87.2441 million CNY, down 55.72% year-on-year [2] - The company has not distributed any dividends in the last three years, with a total payout of 27.0741 million CNY since its A-share listing [3] Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22% from the previous period, with an average of 2,986 circulating shares per person, an increase of 12.64% [2] - Notable institutional shareholders include Caifutong Advantage Industry Rotation Mixed Fund, which increased its holdings by 58.48% to 1.2282 million shares, and new entrants such as GF Healthcare Stock A and others [3]

Core Viewpoint - The stock of Sely Medical has experienced significant fluctuations, with a year-to-date increase of 200.97%, but a recent decline in the last 60 days by 22.70% [1] Group 1: Stock Performance - As of December 23, Sely Medical's stock price is 21.73 CNY per share, with a market capitalization of 4.567 billion CNY [1] - The stock has seen a net inflow of 9.61586 million CNY from major funds, with large orders accounting for 7.11% of total buy and 10.93% of total sell [1] - The stock has appeared on the daily trading leaderboard 37 times this year, with the most recent net buy of 146 million CNY on August 26 [1] Group 2: Financial Performance - For the period from January to September 2025, Sely Medical reported a revenue of 857 million CNY, a year-on-year decrease of 39.64%, and a net profit loss of 87.2441 million CNY, down 55.72% [2] - The company has not distributed any dividends in the last three years, with a total payout of 27.0741 million CNY since its A-share listing [3] Group 3: Shareholder Information - As of December 10, the number of shareholders for Sely Medical is 70,400, a decrease of 11.22%, while the average number of circulating shares per person increased by 12.64% to 2,986 shares [2] - Notable institutional shareholders include Caixin Advantage Industry Rotation Mixed Fund and Guangfa Healthcare Stock A, with significant increases in holdings [3]

Group 1 - The company, Sely Medical (603716), announced that it will hold its first extraordinary shareholders' meeting for 2026 on January 7, 2026 [1]

Group 1 - The core viewpoint of the article highlights that Saily Medical (SH 603716) held its 24th meeting of the fifth board on December 22, 2025, to discuss the expansion of its business scope and corresponding amendments to its articles of association [1] - For the year 2024, Saily Medical's revenue composition is reported as 97.09% from commercial activities and 2.91% from industrial activities [1] - As of the report date, Saily Medical has a market capitalization of 4.7 billion yuan [1] Group 2 - The article also mentions a significant increase in sales for the new energy heavy truck sector, with November sales experiencing a year-on-year growth of 178% [1] - The demand for these trucks is so high that customers are directly visiting factories to expedite orders, indicating a rare market condition not seen in the past decade [1]

塞力斯医疗科技集团股份有限公司 章 程 2025 年 12 月 1 | 第一章 | 总则 3 | | --- | --- | | 第二章 | 经营宗旨和范围 4 | | 第三章 | 股份 5 | | 第一节 | 股份发行 5 | | 第二节 | 股份增减和回购 6 | | 第三节 | 股份转让 7 | | 第四章 | 股东和股东会 8 | | 第一节 | 股东的一般规定 8 | | 第二节 | 控股股东和实际控制人 10 | | 第三节 | 股东会的一般规定 11 | | 第四节 | 股东会的召集 15 | | 第五节 | 股东会的提案与通知 16 | | 第六节 | 股东会的召开 17 | | 第七节 | 股东会的表决和决议 20 | | 第五章 | 董事和董事会 23 | | 第一节 | 董事的一般规定 23 | | 第二节 | 董事会 26 | | 第三节 | 独立董事 31 | | 第四节 | 董事会专门委员会 33 | | 第六章 | 高级管理人员 35 | | 第七章 | 财务会计制度、利润分配和审计 37 | | 第一节 | 财务会计制度 37 | | 第二节 | 内部审计 40 | | 第三节 ...

为满足公司生产经营需要，扩大公司经营范围，拟在公司经营范围的基础上 增加"卫生用品和一次性使用医疗用品销售、化妆品批发、化妆品零售、日用化 学产品销售、日用品批发、日用品销售、个人卫生用品销售、特殊医学用途配方 食品销售"和"食品销售（仅销售预包装食品）、食品互联网销售（仅销售预包 装食品）、保健食品（预包装）销售、互联网销售（除销售需要许可的商品）"， 公司的经营范围以登记机关最终核准的内容为准。 | 证券代码：603716 | 证券简称：塞力医疗 | 公告编号：2025-101 | | --- | --- | --- | | 债券代码:113601 | 债券简称:塞力转债 | | 塞力斯医疗科技集团股份有限公司 关于增加公司经营范围及相应修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 塞力斯医疗科技集团股份有限公司（以下简称"公司"）于 2025 年 12 月 22 日召开公司第五届董事会第二十四次会议，审议通过了《关于增加公司经营 范围及相应修订<公司章程>的议案》，该议案尚需提交公司 2026 ...

证券代码：603716 证券简称：塞力医疗 公告编号：2025-102 塞力斯医疗科技集团股份有限公司 关于召开2026年第一次临时股东会的通知 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一) 股东会类型和届次 2026年第一次临时股东会 召开的日期时间：2026 年 1 月 7 日 14 点 00 分 召开地点：公司（武汉市东西湖区金山大道 1310 号）A 栋 A 会议室 网络投票起止时间：自2026 年 1 月 7 日 至2026 年 1 月 7 日 采用上海证券交易所网络投票系统，通过交易系统投票平台的投票时间为股 东会召开当日的交易时间段，即 9:15-9:25，9:30-11:30，13:00-15:00；通过 互联网投票平台的投票时间为股东会召开当日的 9:15-15:00。 (六) 融资融券、转融通、约定购回业务账户和沪股通投资者的投票程序 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交易所上市公司自律监管指引第 1 ...

重要内容提示： 一、董事会会议召开情况 | 证券代码：603716 | 证券简称：塞力医疗 | 公告编号：2025-100 | | --- | --- | --- | | 债券代码：113601 | 债券简称：塞力转债 | | 塞力斯医疗科技集团股份有限公司 第五届董事会第二十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 塞力斯医疗科技集团股份有限公司(以下简称"公司"）2025 年 12 月 17 日 以邮件方式发送第五届董事会第二十四次会议通知，会议于 2025 年 12 月 22 日 在公司 A 栋 C 会议室以现场和通讯相结合的方式召开。本次会议应到董事 9 人， 实到董事 9 人，会议由董事长温伟先生主持，公司全体高级管理人员列席了会议。 本次董事会经过了适当的通知程序，会议的召集、召开和表决程序符合《公 司法》等相关法律法规和《公司章程》的规定，会议及通过的决议合法有效。 为 0 票。 本议案尚需提交股东会审议。 （二）审议通过《关于提请召开 2026 年第一次临时股东会的议案》 二、董事会会议 ...